NexgenRx (TSE:NXG) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NexgenRx, a Canadian full-service Third-Party Administrator and Technology Solutions Provider, has announced the issuance of 195,312 common shares at $0.32 each, completing the fourth equity payment under its Consulting Agreement with PBM Management Services. The shares, which are part of the company’s compensation for consulting services, will be held for a statutory four-month period expiring November 19, 2024.
For further insights into TSE:NXG stock, check out TipRanks’ Stock Analysis page.